Tsumura & Co. (TSMRF) Stock Price, News & Analysis

Company Overview

Tsumura & Co. is a Tokyo‐based pharmaceutical company specializing in the research, development and manufacture of traditional Japanese herbal medicines, commonly known as Kampo. Established in 1893, the company has built a reputation as Japan’s leading supplier of Kampo formula granules, leveraging more than a century of expertise in integrating botanical ingredients with modern manufacturing processes. Tsumura’s product portfolio includes a wide range of prescription Kampo medicines as well as over-the-counter and consumer healthcare items derived from standardized herbal extracts.

The company’s main business activities encompass formulation design, clinical research and quality-controlled production of herbal medicines. Tsumura operates multiple GMP-certified manufacturing facilities across Japan, ensuring consistency and safety in its granule and tablet products. In addition to its core focus on Kampo, Tsumura invests in botanical drug discovery programs aimed at identifying new therapeutic candidates from natural sources, often collaborating with academic institutions and research organizations to validate efficacy and safety.

Primarily serving the domestic Japanese market, Tsumura also exports selected products to other Asian markets and maintains partnerships for distribution in Europe and North America. Its research centers in Tokyo conduct pharmacological and clinical studies to support both traditional indications and novel applications of herbal compounds. The company’s leadership team draws on extensive experience in pharmaceutical sciences and traditional medicine, guiding Tsumura’s strategy toward innovation in botanically derived therapeutics while upholding rigorous standards of quality and regulatory compliance.

Key Stats

• Today's Range: $23.74 to $23.74
• 50-Day Range: $23.74 to $28.15
• 52-Week Range: $23.74 to $28.15
• Volume: N/A
• Average Volume: 800 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

TSMRF Stock Analysis - Frequently Asked Questions

How have TSMRF shares performed this year?

Tsumura & Co.'s stock was trading at $28.15 at the start of the year. Since then, TSMRF stock has decreased by 15.7% and is now trading at $23.7383.

How do I buy shares of Tsumura & Co.?

Shares of TSMRF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/19/2025
• Next Earnings (Estimated): 8/04/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:TSMRF
• CIK: N/A
• Web: www.tsumura.co.jp
• Phone: 81 3 6361 7101
• Fax: N/A
• Employees: 4,032
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A